MEMSCAP Is Awarded a New Major Innovation Project From the Norwegian Research Council
20 2월 2024 - 2:30AM
Business Wire
MEMSCAP CONTINUES TO BUILD UP ITS
TECHNOLOGICAL ADVANCE WITH THE STEGMA PROGRAM
Regulatory News:
MEMSCAP (Euronext Paris: MEMS) (Paris:MEMS), leading
provider of high-accuracy, high-stability pressure sensor solutions
for the aerospace and medical markets using MEMS technology (Micro
Electro Mechanical Systems), today announced that is awarded a new
major innovation project from the Norwegian Research
Council.
MEMSCAP continues to build up its technological advance with
the STEGMA program.
STEGMA is a new 3-year research project running until 2026 and
targeting the development of a beyond state-of-the-art technology
platform for Pressure Sensor Chip-Stacks. The ultimate goal of this
project is to expand MEMSCAP’s product portfolio and addressed
market segments by integrating those chip-stacks within a large
variety of MEMSCAP’s medical products. Among the different target
applications, respirators (for newborn babies or infants) require
high accuracy and low-pressure range due to limited air flow.
Smaller size paves the way for next generation of implantable
devices and improves MEMSCAP competitive solutions in both the
invasive blood pressure and filtration market segments.
MEMSCAP and SINTEF Digital MiNaLab, Norway’s leading MEMS
research institute, continue their close collaboration to develop
world class innovative technologies and to market new products in
high added value market segments.
Within STEGMA, MEMSCAP and SINTEF will leverage the knowledge
and successful technology built for the aerospace industry within
former research programs in order to expand MEMSCAP medical
products’ portfolio and manufacturing capabilities.
MEMSCAP targets to offer a new world class medical pressure
sensor family of relative, differential and absolute sensor
modules.
Within a grant of 11M NOK (circa 1m€) allocated to MEMSCAP, in
addition to covering all R&D costs of SINTEF, the STEGMA
research activities cover the design of small area chip-stacks and
new processes for high performance 100 mBar, 500 mBar and 1 Bar
differential pressure sensors as well as 1 Bar absolute pressure
sensors.
Verification of the research results cover low-cost
manufacturing capability of chip-stacks and performance testing for
high-end medical sensor applications.
“After the strong support and funding from the Norwegian
Research Council on the technology dedicated to the aerospace
applications in general and the engine control in particular, this
new program comes to support our efforts in building breakthrough
technology for medical applications”, said Roy Grelland, Vice
President, Aeronautics & Medical, of MEMSCAP. “This program
also strengthens the links and strong collaboration we have with
SINTEF”.
“We are very pleased with the close cooperation we have with
MEMSCAP within high-precision pressure MEMS for demanding
applications, which strengthens our position as true pilot line
with a combined R&D and production capacity for advanced MEMS”,
said Mats Carlin, Research Director, Smart Sensors and Microsystems
at SINTEF.
About MEMSCAP
MEMSCAP is a leading provider MEMS based pressure sensors,
best-in-class in term of precision and stability (very low drift)
for two market segments: aerospace and medical.
MEMSCAP also provides variable optical attenuators (VOA) for the
optical communications market.
For more information, visit our website at: www.memscap.com
MEMSCAP is listed on Euronext Paris (Euronext Paris - Memscap -
ISIN code: FR0010298620 - Ticker symbol: MEMS)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240219146396/en/
Yann Cousinet Chief Financial Officer Ph.: +33 (0) 4 76 92 85 00
yann.cousinet@memscap.com
Matthews Emerging Market... (NASDAQ:MEMS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Matthews Emerging Market... (NASDAQ:MEMS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024